Stock Price
1,513.00
Daily Change
11.35 0.76%
Monthly
10.62%
Yearly
26.96%
Q2 Forecast
1,478.96

Aurobindo Pharma reported INR17.73B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Cipla INR 9.55B 3B Mar/2026
Divis Laboratories Ltd INR 8.9B 20M Dec/2025
Dr.Reddys Laboratories INR 6.46B 14.43B Mar/2026
Hindustan Unilever INR 38.41B 530M Mar/2026
Sun Pharmaceuticals INR 49.48B 8.52B Dec/2025
UPL INR 35.58B 12.41B Mar/2026